MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program
Go back to MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program| MACROGENICS (NASDAQ: MGNX) | Delayed: 4.17 +0.05 (1.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.12 | 52 Week High | $36.11 | |||
| Open | $4.17 | 52 Week Low | $14.84 | |||
| Day High | $4.20 | P/E | 10.69 | |||
| Day Low | $4.15 | EPS | $0.39 | |||
| Volume | 44,720 | |||||

